4. Avandia - Top 10 Warnings and Recalls

Drug: Avandia

2006 sales: $3.4 billion

Manufacturer: GlaxoSmithKline

Safety concern: “black box;” heart failure, heart attack

Related Articles:
> New Avandia warning 'a muddle'. Report
> Avandia warning, comeback imminent? Report
> Avandia cleared FDA by one vote. Report
> Avandia, Actos don't boost death risk. Report
> FDA adds to drumbeat of bad news for Avandia. Report
> Expert committee says Avandia should stay. Report
> FDA expert wants Avandia withdrawn. Report
> Docs shunning Avandia in wake of safety study. Report
> Avandia risks exposed under deal to post data. Report

4. Avandia - Top 10 Warnings and Recalls

Suggested Articles

Companies considering this avenue must think through potential implications despite the obvious attraction of early access for patients.

BD says a $1.2 billion investment in its pre-filled syringe business will add surge capacity needed to meet demand in future pandemics.

Ad Environment Matters for Message Receptivity